From pharmaceutical impurities to new drug substances – GLP genotoxicity testing you can rely on
von Laus GmbH
At LAUS, we provide GLP-compliant genotoxicity testing for new drug substances during the preclinical phase, pharmaceutical impurities, degradation products and intermediates, supporting pharmaceutical and biotechnology companies.
Our portfolio includes:
✔ Ames Test (OECD 471)
✔ mini-Ames (Ames MPF Test)
✔ In Vitro Micronucleus Test (OECD 487)
✔ Mouse Lymphoma Tk Gene Mutation Assay (OECD 490)
✔ HPRT Gene Mutation Assay (OECD 476)
Our studies are performed according to current ICH (including ICH M7, ICH S2 and ICH Q3A) and OECD guidelines. Reliable genotoxicity data are an essential part of pharmaceutical drug development and regulatory submissions.
Discover how our scientific expertise can support your pharmaceutical development projects.
#GLP #Genotoxicity #ICHM7 #ICHS2 #OECD #DrugDevelopment #Pharma #Biotech
